[1]Adatsi, R., 2Pappoe, F., 3Bockarie, A. S., 4Derkyi-Kwarteng, L., 5Nsiah, P., 1Weyori, E. W.,
2Dankwa, K., 2Aniakwaa-Bonsu, E., 6Setorglo, J., and *6Acquah, S
1Public Health Reference Laboratory, Tamale Teaching Hospital, Tamale, Ghana
2Department of Microbiology and Immunology, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Ghana
3Department of Internal Medicine and Therapeutics, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Ghana
4Department of Pathology, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Ghana
5Department of Chemical Pathology, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Ghana
6Department of Medical Biochemistry, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Ghana
*Correspondence to: sacquah@ucc.edu.gh
Abstract:
Background: Scientific information on the impact of malaria on the risk of developing type 2 diabetes mellitus (T2DM) after recovery from the coronavirus disease 2019 (COVID-19) is limited in the Ghanaian context. The purpose of this study was to examine the association between selected risk markers of T2DM in falciparum malaria patients post-COVID-19 or not at a tertiary hospital in Ghana. Continue reading “Falciparum malaria is associated with risk markers of type 2 diabetes mellitus in individuals with or without COVID-19 exposure”